# Osteoporosis and Dental Implant

> **NCT00727493** · PHASE4 · UNKNOWN · sponsor: **Charite University, Berlin, Germany** · enrollment: 45 (estimated)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** alendronate once weekly 70mg
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00727493
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-01
- **Primary completion:** 2010-01
- **Final completion:** 2010-04
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2008-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00727493

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00727493, "Osteoporosis and Dental Implant". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00727493. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*